ADS · CUSIP 52490G102 · who reports it, how much, and how much it matters to them
28 of the 720 hedge fund managers we track reported shares of Legend Biotech Corp (Nasdaq: LEGN) on Form 13F for 30 June 2026. Between them they reported USD 602m. The largest position belongs to Suvretta Capital Management, at USD 204m. The manager with the most riding on it is Ivyrock Asset Management (HK), where it is 13.1% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Suvretta Capital Management4 funds on PPLI.com | USD 204m | 3.7% |
| 2 | POINT72 Asset Management17 funds on PPLI.com | USD 89m | 0.1% |
| 3 | Kynam Capital Management1 fund on PPLI.com | USD 87m | 4.8% |
| 4 | Artisan Partners1 fund on PPLI.com | USD 45m | 0.1% |
| 5 | Renaissance Technologies13 funds on PPLI.com | USD 29m | 0.0% |
| 6 | Ivyrock Asset Management (HK)1 fund on PPLI.com | USD 23m | 13.1% |
| 7 | ECOR1 Capital3 funds on PPLI.com | USD 23m | 1.1% |
| 8 | Squarepoint Ops7 funds on PPLI.com | USD 22m | 0.0% |
| 9 | Adage Capital Management1 fund on PPLI.com | USD 17m | 0.0% |
| 10 | Arrowmark Colorado Holdings24 funds on PPLI.com | USD 10m | 0.4% |
| 11 | Hudson Bay Capital Management8 funds on PPLI.com | USD 9.8m | 0.0% |
| 12 | Resolute Capital Asset Partners1 fund on PPLI.com | USD 7.5m | 3.2% |
| 13 | Burkehill Global Management5 funds on PPLI.com | USD 7.2m | 0.3% |
| 14 | Balyasny Asset Management25 funds on PPLI.com | USD 6.1m | 0.0% |
| 15 | Marshall Wace LLP84 funds on PPLI.com | USD 5.8m | 0.0% |
| 16 | Polymer Capital Management (HK)1 fund on PPLI.com | USD 4.8m | 0.2% |
| 17 | Two Sigma Investments35 funds on PPLI.com | USD 4.7m | 0.0% |
| 18 | Citadel Advisors32 funds on PPLI.com | USD 986,000 | 0.0% |
| 19 | Rock Springs Capital Management2 funds on PPLI.com | USD 967,000 | 0.0% |
| 20 | Tudor Investment Corporation10 funds on PPLI.com | USD 839,000 | 0.0% |
| 21 | LMR Partners2 funds on PPLI.com | USD 578,000 | 0.0% |
| 22 | Engineers Gate Manager1 fund on PPLI.com | USD 543,000 | 0.0% |
| 23 | Cinctive Capital Management5 funds on PPLI.com | USD 522,000 | 0.0% |
| 24 | Jain Global1 fund on PPLI.com | USD 518,000 | 0.0% |
| 25 | Diametric Capital2 funds on PPLI.com | USD 289,000 | 0.0% |
| 26 | Persistent Asset Partners10 funds on PPLI.com | USD 277,000 | 0.1% |
| 27 | Freestone Grove Partners1 fund on PPLI.com | USD 159,000 | 0.0% |
| 28 | Bayforest Capital1 fund on PPLI.com | USD 34,569 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Ivyrock Asset Management (HK) | USD 23m | 13.1% |
| 2 | Kynam Capital Management | USD 87m | 4.8% |
| 3 | Suvretta Capital Management | USD 204m | 3.7% |
| 4 | Resolute Capital Asset Partners | USD 7.5m | 3.2% |
| 5 | ECOR1 Capital | USD 23m | 1.1% |
| 6 | Arrowmark Colorado Holdings | USD 10m | 0.4% |
| 7 | Burkehill Global Management | USD 7.2m | 0.3% |
| 8 | Polymer Capital Management (HK) | USD 4.8m | 0.2% |
| 9 | POINT72 Asset Management | USD 89m | 0.1% |
| 10 | Persistent Asset Partners | USD 277,000 | 0.1% |
Legend Biotech Corp trades under the symbol LEGN on the Nasdaq. Its CUSIP, the code used on Form 13F, is 52490G102.
28 of the 720 hedge fund managers PPLI.com tracks reported Legend Biotech Corp shares on Form 13F for 30 June 2026. The largest reported positions were held by Suvretta Capital Management (USD 204m), POINT72 Asset Management (USD 89m), Kynam Capital Management (USD 87m), Artisan Partners (USD 45m) and Renaissance Technologies (USD 29m).
28 managers in our coverage reported it, and between them they run 298 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Ivyrock Asset Management (HK), where the position was 13.1% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Legend Biotech Corp or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.